nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—ALB—Estropipate—osteoporosis	0.153	0.318	CbGbCtD
Rufinamide—ALB—Estradiol—osteoporosis	0.0637	0.132	CbGbCtD
Rufinamide—CYP3A4—Estropipate—osteoporosis	0.048	0.0997	CbGbCtD
Rufinamide—CYP3A4—Calcitriol—osteoporosis	0.048	0.0997	CbGbCtD
Rufinamide—CYP3A4—Ergocalciferol—osteoporosis	0.0384	0.0797	CbGbCtD
Rufinamide—CYP3A4—Raloxifene—osteoporosis	0.0321	0.0665	CbGbCtD
Rufinamide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.031	0.0643	CbGbCtD
Rufinamide—CYP3A4—Cholecalciferol—osteoporosis	0.0248	0.0514	CbGbCtD
Rufinamide—CYP3A4—Conjugated Estrogens—osteoporosis	0.0227	0.0472	CbGbCtD
Rufinamide—CYP3A4—Estradiol—osteoporosis	0.02	0.0414	CbGbCtD
Rufinamide—Insomnia—Raloxifene—osteoporosis	0.000763	0.00184	CcSEcCtD
Rufinamide—Immune system disorder—Zoledronate—osteoporosis	0.00076	0.00184	CcSEcCtD
Rufinamide—Mediastinal disorder—Zoledronate—osteoporosis	0.000759	0.00183	CcSEcCtD
Rufinamide—Vertigo—Risedronate—osteoporosis	0.000758	0.00183	CcSEcCtD
Rufinamide—Eye disorder—Conjugated Estrogens—osteoporosis	0.000757	0.00183	CcSEcCtD
Rufinamide—Insomnia—Ibandronate—osteoporosis	0.000756	0.00183	CcSEcCtD
Rufinamide—Dyspepsia—Alendronate—osteoporosis	0.000756	0.00182	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Estropipate—osteoporosis	0.000752	0.00182	CcSEcCtD
Rufinamide—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000752	0.00182	CcSEcCtD
Rufinamide—Fatigue—Estropipate—osteoporosis	0.000751	0.00181	CcSEcCtD
Rufinamide—Pollakiuria—Estradiol—osteoporosis	0.000749	0.00181	CcSEcCtD
Rufinamide—Constipation—Estropipate—osteoporosis	0.000745	0.0018	CcSEcCtD
Rufinamide—Dyspepsia—Raloxifene—osteoporosis	0.000743	0.00179	CcSEcCtD
Rufinamide—Hypersensitivity—Etidronic acid—osteoporosis	0.000742	0.00179	CcSEcCtD
Rufinamide—Anaemia—Pamidronate—osteoporosis	0.000741	0.00179	CcSEcCtD
Rufinamide—Insomnia—Calcitriol—osteoporosis	0.00074	0.00179	CcSEcCtD
Rufinamide—Mental disorder—Zoledronate—osteoporosis	0.000737	0.00178	CcSEcCtD
Rufinamide—Agitation—Pamidronate—osteoporosis	0.000737	0.00178	CcSEcCtD
Rufinamide—Dyspepsia—Ibandronate—osteoporosis	0.000736	0.00178	CcSEcCtD
Rufinamide—Anxiety—Ethinyl Estradiol—osteoporosis	0.000734	0.00177	CcSEcCtD
Rufinamide—Constipation—Alendronate—osteoporosis	0.000734	0.00177	CcSEcCtD
Rufinamide—Weight decreased—Estradiol—osteoporosis	0.000733	0.00177	CcSEcCtD
Rufinamide—Malnutrition—Zoledronate—osteoporosis	0.000733	0.00177	CcSEcCtD
Rufinamide—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000732	0.00177	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000732	0.00177	CcSEcCtD
Rufinamide—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.00073	0.00176	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000729	0.00176	CcSEcCtD
Rufinamide—Somnolence—Calcitriol—osteoporosis	0.000727	0.00176	CcSEcCtD
Rufinamide—Pneumonia—Estradiol—osteoporosis	0.000727	0.00176	CcSEcCtD
Rufinamide—Decreased appetite—Ibandronate—osteoporosis	0.000726	0.00175	CcSEcCtD
Rufinamide—Infestation NOS—Estradiol—osteoporosis	0.000723	0.00175	CcSEcCtD
Rufinamide—Infestation—Estradiol—osteoporosis	0.000723	0.00175	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000721	0.00174	CcSEcCtD
Rufinamide—Fatigue—Ibandronate—osteoporosis	0.00072	0.00174	CcSEcCtD
Rufinamide—Leukopenia—Pamidronate—osteoporosis	0.000718	0.00173	CcSEcCtD
Rufinamide—Anxiety—Risedronate—osteoporosis	0.000716	0.00173	CcSEcCtD
Rufinamide—Constipation—Ibandronate—osteoporosis	0.000715	0.00173	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000713	0.00172	CcSEcCtD
Rufinamide—Pruritus—Etidronic acid—osteoporosis	0.000713	0.00172	CcSEcCtD
Rufinamide—Decreased appetite—Calcitriol—osteoporosis	0.000711	0.00172	CcSEcCtD
Rufinamide—Mental disorder—Conjugated Estrogens—osteoporosis	0.00071	0.00171	CcSEcCtD
Rufinamide—Back pain—Zoledronate—osteoporosis	0.000709	0.00171	CcSEcCtD
Rufinamide—Malnutrition—Conjugated Estrogens—osteoporosis	0.000706	0.0017	CcSEcCtD
Rufinamide—Infection—Ethinyl Estradiol—osteoporosis	0.000702	0.00169	CcSEcCtD
Rufinamide—Constipation—Calcitriol—osteoporosis	0.0007	0.00169	CcSEcCtD
Rufinamide—Convulsion—Pamidronate—osteoporosis	0.000695	0.00168	CcSEcCtD
Rufinamide—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000693	0.00167	CcSEcCtD
Rufinamide—Vision blurred—Zoledronate—osteoporosis	0.000691	0.00167	CcSEcCtD
Rufinamide—Diarrhoea—Etidronic acid—osteoporosis	0.000689	0.00166	CcSEcCtD
Rufinamide—Haematuria—Estradiol—osteoporosis	0.000689	0.00166	CcSEcCtD
Rufinamide—Tremor—Zoledronate—osteoporosis	0.000686	0.00166	CcSEcCtD
Rufinamide—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000686	0.00166	CcSEcCtD
Rufinamide—Infection—Risedronate—osteoporosis	0.000684	0.00165	CcSEcCtD
Rufinamide—Hepatobiliary disease—Estradiol—osteoporosis	0.000683	0.00165	CcSEcCtD
Rufinamide—Back pain—Conjugated Estrogens—osteoporosis	0.000682	0.00165	CcSEcCtD
Rufinamide—Epistaxis—Estradiol—osteoporosis	0.000682	0.00165	CcSEcCtD
Rufinamide—Anxiety—Pamidronate—osteoporosis	0.000681	0.00164	CcSEcCtD
Rufinamide—Sinusitis—Estradiol—osteoporosis	0.000678	0.00164	CcSEcCtD
Rufinamide—Anaemia—Zoledronate—osteoporosis	0.000677	0.00164	CcSEcCtD
Rufinamide—Nervous system disorder—Risedronate—osteoporosis	0.000675	0.00163	CcSEcCtD
Rufinamide—Agitation—Zoledronate—osteoporosis	0.000673	0.00163	CcSEcCtD
Rufinamide—Skin disorder—Risedronate—osteoporosis	0.000669	0.00162	CcSEcCtD
Rufinamide—Vision blurred—Conjugated Estrogens—osteoporosis	0.000665	0.00161	CcSEcCtD
Rufinamide—Vertigo—Zoledronate—osteoporosis	0.000658	0.00159	CcSEcCtD
Rufinamide—Leukopenia—Zoledronate—osteoporosis	0.000656	0.00158	CcSEcCtD
Rufinamide—Infection—Pamidronate—osteoporosis	0.00065	0.00157	CcSEcCtD
Rufinamide—Rhinitis—Estradiol—osteoporosis	0.00065	0.00157	CcSEcCtD
Rufinamide—Hypersensitivity—Estropipate—osteoporosis	0.000642	0.00155	CcSEcCtD
Rufinamide—Nervous system disorder—Pamidronate—osteoporosis	0.000642	0.00155	CcSEcCtD
Rufinamide—Thrombocytopenia—Pamidronate—osteoporosis	0.000641	0.00155	CcSEcCtD
Rufinamide—Urinary tract disorder—Estradiol—osteoporosis	0.000641	0.00155	CcSEcCtD
Rufinamide—Vomiting—Etidronic acid—osteoporosis	0.00064	0.00155	CcSEcCtD
Rufinamide—Urethral disorder—Estradiol—osteoporosis	0.000636	0.00154	CcSEcCtD
Rufinamide—Rash—Etidronic acid—osteoporosis	0.000635	0.00153	CcSEcCtD
Rufinamide—Convulsion—Zoledronate—osteoporosis	0.000635	0.00153	CcSEcCtD
Rufinamide—Dermatitis—Etidronic acid—osteoporosis	0.000635	0.00153	CcSEcCtD
Rufinamide—Vertigo—Conjugated Estrogens—osteoporosis	0.000634	0.00153	CcSEcCtD
Rufinamide—Hypersensitivity—Alendronate—osteoporosis	0.000632	0.00153	CcSEcCtD
Rufinamide—Headache—Etidronic acid—osteoporosis	0.000631	0.00152	CcSEcCtD
Rufinamide—Asthenia—Estropipate—osteoporosis	0.000625	0.00151	CcSEcCtD
Rufinamide—Anorexia—Pamidronate—osteoporosis	0.000624	0.00151	CcSEcCtD
Rufinamide—Insomnia—Risedronate—osteoporosis	0.000623	0.0015	CcSEcCtD
Rufinamide—Anxiety—Zoledronate—osteoporosis	0.000622	0.0015	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00062	0.0015	CcSEcCtD
Rufinamide—Pruritus—Estropipate—osteoporosis	0.000617	0.00149	CcSEcCtD
Rufinamide—Asthenia—Alendronate—osteoporosis	0.000616	0.00149	CcSEcCtD
Rufinamide—Hypersensitivity—Ibandronate—osteoporosis	0.000616	0.00149	CcSEcCtD
Rufinamide—Convulsion—Conjugated Estrogens—osteoporosis	0.000611	0.00148	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00061	0.00147	CcSEcCtD
Rufinamide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000609	0.00147	CcSEcCtD
Rufinamide—Pruritus—Alendronate—osteoporosis	0.000607	0.00147	CcSEcCtD
Rufinamide—Dyspepsia—Risedronate—osteoporosis	0.000606	0.00146	CcSEcCtD
Rufinamide—Eye disorder—Estradiol—osteoporosis	0.000606	0.00146	CcSEcCtD
Rufinamide—Constipation—Ethinyl Estradiol—osteoporosis	0.000604	0.00146	CcSEcCtD
Rufinamide—Hypersensitivity—Calcitriol—osteoporosis	0.000603	0.00146	CcSEcCtD
Rufinamide—Cardiac disorder—Estradiol—osteoporosis	0.000602	0.00145	CcSEcCtD
Rufinamide—Asthenia—Ibandronate—osteoporosis	0.0006	0.00145	CcSEcCtD
Rufinamide—Anxiety—Conjugated Estrogens—osteoporosis	0.000599	0.00145	CcSEcCtD
Rufinamide—Nausea—Etidronic acid—osteoporosis	0.000598	0.00145	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000597	0.00144	CcSEcCtD
Rufinamide—Diarrhoea—Estropipate—osteoporosis	0.000596	0.00144	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Risedronate—osteoporosis	0.000595	0.00144	CcSEcCtD
Rufinamide—Infection—Zoledronate—osteoporosis	0.000594	0.00143	CcSEcCtD
Rufinamide—Fatigue—Risedronate—osteoporosis	0.000594	0.00143	CcSEcCtD
Rufinamide—Insomnia—Pamidronate—osteoporosis	0.000592	0.00143	CcSEcCtD
Rufinamide—Pruritus—Ibandronate—osteoporosis	0.000591	0.00143	CcSEcCtD
Rufinamide—Constipation—Risedronate—osteoporosis	0.000589	0.00142	CcSEcCtD
Rufinamide—Diarrhoea—Alendronate—osteoporosis	0.000587	0.00142	CcSEcCtD
Rufinamide—Asthenia—Calcitriol—osteoporosis	0.000587	0.00142	CcSEcCtD
Rufinamide—Nervous system disorder—Zoledronate—osteoporosis	0.000586	0.00142	CcSEcCtD
Rufinamide—Immune system disorder—Estradiol—osteoporosis	0.000586	0.00142	CcSEcCtD
Rufinamide—Thrombocytopenia—Zoledronate—osteoporosis	0.000586	0.00141	CcSEcCtD
Rufinamide—Mediastinal disorder—Estradiol—osteoporosis	0.000585	0.00141	CcSEcCtD
Rufinamide—Somnolence—Pamidronate—osteoporosis	0.000582	0.00141	CcSEcCtD
Rufinamide—Skin disorder—Zoledronate—osteoporosis	0.000581	0.0014	CcSEcCtD
Rufinamide—Pruritus—Calcitriol—osteoporosis	0.000579	0.0014	CcSEcCtD
Rufinamide—Diarrhoea—Raloxifene—osteoporosis	0.000578	0.00139	CcSEcCtD
Rufinamide—Dyspepsia—Pamidronate—osteoporosis	0.000576	0.00139	CcSEcCtD
Rufinamide—Dizziness—Estropipate—osteoporosis	0.000576	0.00139	CcSEcCtD
Rufinamide—Infection—Conjugated Estrogens—osteoporosis	0.000572	0.00138	CcSEcCtD
Rufinamide—Diarrhoea—Ibandronate—osteoporosis	0.000572	0.00138	CcSEcCtD
Rufinamide—Anorexia—Zoledronate—osteoporosis	0.00057	0.00138	CcSEcCtD
Rufinamide—Decreased appetite—Pamidronate—osteoporosis	0.000569	0.00137	CcSEcCtD
Rufinamide—Mental disorder—Estradiol—osteoporosis	0.000568	0.00137	CcSEcCtD
Rufinamide—Dizziness—Alendronate—osteoporosis	0.000568	0.00137	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000565	0.00137	CcSEcCtD
Rufinamide—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000565	0.00136	CcSEcCtD
Rufinamide—Malnutrition—Estradiol—osteoporosis	0.000565	0.00136	CcSEcCtD
Rufinamide—Fatigue—Pamidronate—osteoporosis	0.000564	0.00136	CcSEcCtD
Rufinamide—Constipation—Pamidronate—osteoporosis	0.00056	0.00135	CcSEcCtD
Rufinamide—Diarrhoea—Calcitriol—osteoporosis	0.00056	0.00135	CcSEcCtD
Rufinamide—Skin disorder—Conjugated Estrogens—osteoporosis	0.000559	0.00135	CcSEcCtD
Rufinamide—Dizziness—Raloxifene—osteoporosis	0.000558	0.00135	CcSEcCtD
Rufinamide—Vomiting—Estropipate—osteoporosis	0.000554	0.00134	CcSEcCtD
Rufinamide—Dizziness—Ibandronate—osteoporosis	0.000553	0.00133	CcSEcCtD
Rufinamide—Rash—Estropipate—osteoporosis	0.000549	0.00133	CcSEcCtD
Rufinamide—Dermatitis—Estropipate—osteoporosis	0.000549	0.00133	CcSEcCtD
Rufinamide—Anorexia—Conjugated Estrogens—osteoporosis	0.000549	0.00133	CcSEcCtD
Rufinamide—Back pain—Estradiol—osteoporosis	0.000546	0.00132	CcSEcCtD
Rufinamide—Headache—Estropipate—osteoporosis	0.000546	0.00132	CcSEcCtD
Rufinamide—Vomiting—Alendronate—osteoporosis	0.000546	0.00132	CcSEcCtD
Rufinamide—Rash—Alendronate—osteoporosis	0.000541	0.00131	CcSEcCtD
Rufinamide—Insomnia—Zoledronate—osteoporosis	0.000541	0.00131	CcSEcCtD
Rufinamide—Dermatitis—Alendronate—osteoporosis	0.000541	0.00131	CcSEcCtD
Rufinamide—Headache—Alendronate—osteoporosis	0.000538	0.0013	CcSEcCtD
Rufinamide—Vomiting—Raloxifene—osteoporosis	0.000537	0.0013	CcSEcCtD
Rufinamide—Rash—Raloxifene—osteoporosis	0.000532	0.00129	CcSEcCtD
Rufinamide—Dermatitis—Raloxifene—osteoporosis	0.000532	0.00128	CcSEcCtD
Rufinamide—Somnolence—Zoledronate—osteoporosis	0.000532	0.00128	CcSEcCtD
Rufinamide—Vomiting—Ibandronate—osteoporosis	0.000531	0.00128	CcSEcCtD
Rufinamide—Tremor—Estradiol—osteoporosis	0.000529	0.00128	CcSEcCtD
Rufinamide—Headache—Raloxifene—osteoporosis	0.000529	0.00128	CcSEcCtD
Rufinamide—Rash—Ibandronate—osteoporosis	0.000527	0.00127	CcSEcCtD
Rufinamide—Dermatitis—Ibandronate—osteoporosis	0.000526	0.00127	CcSEcCtD
Rufinamide—Dyspepsia—Zoledronate—osteoporosis	0.000526	0.00127	CcSEcCtD
Rufinamide—Headache—Ibandronate—osteoporosis	0.000524	0.00126	CcSEcCtD
Rufinamide—Insomnia—Conjugated Estrogens—osteoporosis	0.000521	0.00126	CcSEcCtD
Rufinamide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00052	0.00126	CcSEcCtD
Rufinamide—Vomiting—Calcitriol—osteoporosis	0.00052	0.00126	CcSEcCtD
Rufinamide—Decreased appetite—Zoledronate—osteoporosis	0.00052	0.00126	CcSEcCtD
Rufinamide—Agitation—Estradiol—osteoporosis	0.000519	0.00125	CcSEcCtD
Rufinamide—Nausea—Estropipate—osteoporosis	0.000518	0.00125	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000516	0.00125	CcSEcCtD
Rufinamide—Rash—Calcitriol—osteoporosis	0.000516	0.00125	CcSEcCtD
Rufinamide—Fatigue—Zoledronate—osteoporosis	0.000516	0.00125	CcSEcCtD
Rufinamide—Dermatitis—Calcitriol—osteoporosis	0.000515	0.00124	CcSEcCtD
Rufinamide—Headache—Calcitriol—osteoporosis	0.000512	0.00124	CcSEcCtD
Rufinamide—Somnolence—Conjugated Estrogens—osteoporosis	0.000512	0.00124	CcSEcCtD
Rufinamide—Constipation—Zoledronate—osteoporosis	0.000511	0.00124	CcSEcCtD
Rufinamide—Nausea—Alendronate—osteoporosis	0.00051	0.00123	CcSEcCtD
Rufinamide—Hypersensitivity—Risedronate—osteoporosis	0.000507	0.00123	CcSEcCtD
Rufinamide—Vertigo—Estradiol—osteoporosis	0.000507	0.00123	CcSEcCtD
Rufinamide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000507	0.00122	CcSEcCtD
Rufinamide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000507	0.00122	CcSEcCtD
Rufinamide—Nausea—Raloxifene—osteoporosis	0.000501	0.00121	CcSEcCtD
Rufinamide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000501	0.00121	CcSEcCtD
Rufinamide—Pruritus—Ethinyl Estradiol—osteoporosis	0.0005	0.00121	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000497	0.0012	CcSEcCtD
Rufinamide—Fatigue—Conjugated Estrogens—osteoporosis	0.000496	0.0012	CcSEcCtD
Rufinamide—Nausea—Ibandronate—osteoporosis	0.000496	0.0012	CcSEcCtD
Rufinamide—Asthenia—Risedronate—osteoporosis	0.000494	0.00119	CcSEcCtD
Rufinamide—Constipation—Conjugated Estrogens—osteoporosis	0.000492	0.00119	CcSEcCtD
Rufinamide—Pruritus—Risedronate—osteoporosis	0.000487	0.00118	CcSEcCtD
Rufinamide—Nausea—Calcitriol—osteoporosis	0.000486	0.00117	CcSEcCtD
Rufinamide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000483	0.00117	CcSEcCtD
Rufinamide—Hypersensitivity—Pamidronate—osteoporosis	0.000482	0.00116	CcSEcCtD
Rufinamide—Anxiety—Estradiol—osteoporosis	0.000479	0.00116	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000477	0.00115	CcSEcCtD
Rufinamide—Diarrhoea—Risedronate—osteoporosis	0.000471	0.00114	CcSEcCtD
Rufinamide—Asthenia—Pamidronate—osteoporosis	0.00047	0.00113	CcSEcCtD
Rufinamide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000467	0.00113	CcSEcCtD
Rufinamide—Pruritus—Pamidronate—osteoporosis	0.000463	0.00112	CcSEcCtD
Rufinamide—Infection—Estradiol—osteoporosis	0.000458	0.00111	CcSEcCtD
Rufinamide—Dizziness—Risedronate—osteoporosis	0.000455	0.0011	CcSEcCtD
Rufinamide—Nervous system disorder—Estradiol—osteoporosis	0.000452	0.00109	CcSEcCtD
Rufinamide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000449	0.00108	CcSEcCtD
Rufinamide—Diarrhoea—Pamidronate—osteoporosis	0.000448	0.00108	CcSEcCtD
Rufinamide—Skin disorder—Estradiol—osteoporosis	0.000448	0.00108	CcSEcCtD
Rufinamide—Rash—Ethinyl Estradiol—osteoporosis	0.000445	0.00108	CcSEcCtD
Rufinamide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000445	0.00107	CcSEcCtD
Rufinamide—Headache—Ethinyl Estradiol—osteoporosis	0.000443	0.00107	CcSEcCtD
Rufinamide—Hypersensitivity—Zoledronate—osteoporosis	0.000441	0.00106	CcSEcCtD
Rufinamide—Vomiting—Risedronate—osteoporosis	0.000438	0.00106	CcSEcCtD
Rufinamide—Rash—Risedronate—osteoporosis	0.000434	0.00105	CcSEcCtD
Rufinamide—Dermatitis—Risedronate—osteoporosis	0.000434	0.00105	CcSEcCtD
Rufinamide—Dizziness—Pamidronate—osteoporosis	0.000433	0.00105	CcSEcCtD
Rufinamide—Headache—Risedronate—osteoporosis	0.000431	0.00104	CcSEcCtD
Rufinamide—Asthenia—Zoledronate—osteoporosis	0.000429	0.00104	CcSEcCtD
Rufinamide—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000424	0.00102	CcSEcCtD
Rufinamide—Pruritus—Zoledronate—osteoporosis	0.000423	0.00102	CcSEcCtD
Rufinamide—Nausea—Ethinyl Estradiol—osteoporosis	0.00042	0.00101	CcSEcCtD
Rufinamide—Insomnia—Estradiol—osteoporosis	0.000417	0.00101	CcSEcCtD
Rufinamide—Vomiting—Pamidronate—osteoporosis	0.000416	0.00101	CcSEcCtD
Rufinamide—Asthenia—Conjugated Estrogens—osteoporosis	0.000413	0.000998	CcSEcCtD
Rufinamide—Rash—Pamidronate—osteoporosis	0.000413	0.000997	CcSEcCtD
Rufinamide—Dermatitis—Pamidronate—osteoporosis	0.000412	0.000996	CcSEcCtD
Rufinamide—Headache—Pamidronate—osteoporosis	0.00041	0.000991	CcSEcCtD
Rufinamide—Somnolence—Estradiol—osteoporosis	0.00041	0.000989	CcSEcCtD
Rufinamide—Diarrhoea—Zoledronate—osteoporosis	0.000409	0.000988	CcSEcCtD
Rufinamide—Nausea—Risedronate—osteoporosis	0.000409	0.000988	CcSEcCtD
Rufinamide—Pruritus—Conjugated Estrogens—osteoporosis	0.000407	0.000984	CcSEcCtD
Rufinamide—Dyspepsia—Estradiol—osteoporosis	0.000406	0.00098	CcSEcCtD
Rufinamide—Decreased appetite—Estradiol—osteoporosis	0.000401	0.000968	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Estradiol—osteoporosis	0.000398	0.000961	CcSEcCtD
Rufinamide—Fatigue—Estradiol—osteoporosis	0.000397	0.00096	CcSEcCtD
Rufinamide—Dizziness—Zoledronate—osteoporosis	0.000395	0.000955	CcSEcCtD
Rufinamide—Constipation—Estradiol—osteoporosis	0.000394	0.000952	CcSEcCtD
Rufinamide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000394	0.000952	CcSEcCtD
Rufinamide—Nausea—Pamidronate—osteoporosis	0.000389	0.000939	CcSEcCtD
Rufinamide—Dizziness—Conjugated Estrogens—osteoporosis	0.000381	0.00092	CcSEcCtD
Rufinamide—Vomiting—Zoledronate—osteoporosis	0.00038	0.000918	CcSEcCtD
Rufinamide—Rash—Zoledronate—osteoporosis	0.000377	0.000911	CcSEcCtD
Rufinamide—Dermatitis—Zoledronate—osteoporosis	0.000377	0.00091	CcSEcCtD
Rufinamide—Headache—Zoledronate—osteoporosis	0.000375	0.000905	CcSEcCtD
Rufinamide—Vomiting—Conjugated Estrogens—osteoporosis	0.000366	0.000884	CcSEcCtD
Rufinamide—Rash—Conjugated Estrogens—osteoporosis	0.000363	0.000877	CcSEcCtD
Rufinamide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000363	0.000876	CcSEcCtD
Rufinamide—Headache—Conjugated Estrogens—osteoporosis	0.000361	0.000871	CcSEcCtD
Rufinamide—Nausea—Zoledronate—osteoporosis	0.000355	0.000858	CcSEcCtD
Rufinamide—Nausea—Conjugated Estrogens—osteoporosis	0.000342	0.000826	CcSEcCtD
Rufinamide—Hypersensitivity—Estradiol—osteoporosis	0.00034	0.00082	CcSEcCtD
Rufinamide—Asthenia—Estradiol—osteoporosis	0.000331	0.000799	CcSEcCtD
Rufinamide—Pruritus—Estradiol—osteoporosis	0.000326	0.000787	CcSEcCtD
Rufinamide—Diarrhoea—Estradiol—osteoporosis	0.000315	0.000762	CcSEcCtD
Rufinamide—Dizziness—Estradiol—osteoporosis	0.000305	0.000736	CcSEcCtD
Rufinamide—Vomiting—Estradiol—osteoporosis	0.000293	0.000708	CcSEcCtD
Rufinamide—Rash—Estradiol—osteoporosis	0.000291	0.000702	CcSEcCtD
Rufinamide—Dermatitis—Estradiol—osteoporosis	0.00029	0.000701	CcSEcCtD
Rufinamide—Headache—Estradiol—osteoporosis	0.000289	0.000697	CcSEcCtD
Rufinamide—Nausea—Estradiol—osteoporosis	0.000274	0.000661	CcSEcCtD
Rufinamide—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.000226	0.00217	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TLN1—osteoporosis	0.000225	0.00217	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—LEP—osteoporosis	0.000225	0.00216	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000224	0.00216	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—IL6R—osteoporosis	0.000216	0.00207	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—SOD2—osteoporosis	0.000213	0.00205	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.000207	0.00199	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—GPX1—osteoporosis	0.000203	0.00195	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—LEP—osteoporosis	0.000201	0.00193	CbGpPWpGaD
Rufinamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.0002	0.00192	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000195	0.00187	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—P4HB—osteoporosis	0.000194	0.00187	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—WNT1—osteoporosis	0.000191	0.00183	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTH—osteoporosis	0.000189	0.00182	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—IL6R—osteoporosis	0.000189	0.00181	CbGpPWpGaD
Rufinamide—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000188	0.00181	CbGpPWpGaD
Rufinamide—CES1—NRF2 pathway—TGFB1—osteoporosis	0.000187	0.0018	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—MTHFR—osteoporosis	0.000187	0.0018	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—RAP1A—osteoporosis	0.000186	0.00179	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—WDR1—osteoporosis	0.000185	0.00178	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CNR2—osteoporosis	0.000184	0.00177	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—LEP—osteoporosis	0.000184	0.00176	CbGpPWpGaD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000183	0.00176	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—ADCY5—osteoporosis	0.000183	0.00176	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NFATC1—osteoporosis	0.000181	0.00174	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—DKK1—osteoporosis	0.00018	0.00173	CbGpPWpGaD
Rufinamide—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.00018	0.00173	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000178	0.00171	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000176	0.00169	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—IL6R—osteoporosis	0.000174	0.00168	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—WNT1—osteoporosis	0.000173	0.00166	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	0.000169	0.00163	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—FGA—osteoporosis	0.000169	0.00162	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—IL6R—osteoporosis	0.000168	0.00162	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—IL6R—osteoporosis	0.000167	0.0016	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—ADCY5—osteoporosis	0.000166	0.0016	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	0.000161	0.00155	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—IL6R—osteoporosis	0.00016	0.00154	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—IL6R—osteoporosis	0.00016	0.00154	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—BMP2—osteoporosis	0.000157	0.00151	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTHLH—osteoporosis	0.000157	0.00151	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—IL6R—osteoporosis	0.000154	0.00148	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—IL6R—osteoporosis	0.000154	0.00148	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—IL6R—osteoporosis	0.000154	0.00148	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—FGB—osteoporosis	0.000153	0.00147	CbGpPWpGaD
Rufinamide—CYP2E1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000153	0.00147	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000149	0.00143	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—LEP—osteoporosis	0.000148	0.00143	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000148	0.00142	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PSMA5—osteoporosis	0.000148	0.00142	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PSMA2—osteoporosis	0.000148	0.00142	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000148	0.00142	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000147	0.00141	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CAP1—osteoporosis	0.000147	0.00141	CbGpPWpGaD
Rufinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000145	0.0014	CbGpPWpGaD
Rufinamide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000143	0.00138	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—LEP—osteoporosis	0.000142	0.00136	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.00014	0.00134	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CALCA—osteoporosis	0.000138	0.00133	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	0.000137	0.00131	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—LEP—osteoporosis	0.000136	0.00131	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—LEP—osteoporosis	0.000136	0.00131	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—CYP19A1—osteoporosis	0.000135	0.0013	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—POMC—osteoporosis	0.000135	0.00129	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000133	0.00128	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—CYP19A1—osteoporosis	0.000133	0.00128	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—LEP—osteoporosis	0.000132	0.00126	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—LEP—osteoporosis	0.000132	0.00126	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KL—osteoporosis	0.000125	0.0012	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—IL6R—osteoporosis	0.000124	0.0012	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—IGF1—osteoporosis	0.000124	0.00119	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—POMC—osteoporosis	0.000122	0.00117	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000121	0.00116	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—IL6R—osteoporosis	0.000119	0.00115	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000119	0.00114	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—IL6R—osteoporosis	0.000119	0.00114	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000118	0.00113	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.000118	0.00113	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—IL6—osteoporosis	0.000118	0.00113	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000118	0.00113	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MGLL—osteoporosis	0.000116	0.00112	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—IL6R—osteoporosis	0.000114	0.0011	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—IL6R—osteoporosis	0.000114	0.0011	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—TGFB1—osteoporosis	0.000112	0.00107	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—IL1B—osteoporosis	0.000111	0.00107	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—IL6R—osteoporosis	0.00011	0.00106	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—IL6R—osteoporosis	0.00011	0.00106	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000109	0.00105	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—IL6R—osteoporosis	0.000109	0.00104	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—TNF—osteoporosis	0.000108	0.00103	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—ANXA2—osteoporosis	0.000107	0.00102	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PLEK—osteoporosis	0.000107	0.00102	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000106	0.00102	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—IL6—osteoporosis	0.000105	0.00101	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—TNF—osteoporosis	0.000104	0.001	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—TGFB1—osteoporosis	9.94e-05	0.000955	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	9.92e-05	0.000954	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ADCY5—osteoporosis	9.81e-05	0.000943	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—IL6—osteoporosis	9.6e-05	0.000923	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SPP1—osteoporosis	9.49e-05	0.000912	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—TNF—osteoporosis	9.28e-05	0.000892	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—LEP—osteoporosis	9.25e-05	0.000889	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	9.22e-05	0.000886	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TLN1—osteoporosis	9.18e-05	0.000882	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—TGFB1—osteoporosis	9.09e-05	0.000874	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VCL—osteoporosis	9.06e-05	0.00087	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	8.84e-05	0.000849	CbGpPWpGaD
Rufinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	8.74e-05	0.000839	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—IL6—osteoporosis	8.68e-05	0.000834	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IRS2—osteoporosis	8.58e-05	0.000825	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—TNF—osteoporosis	8.49e-05	0.000816	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.48e-05	0.000814	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—IL6—osteoporosis	8.4e-05	0.000808	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—LEP—osteoporosis	8.4e-05	0.000807	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—POMC—osteoporosis	8.11e-05	0.000779	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TNF—osteoporosis	8.07e-05	0.000776	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ESR1—osteoporosis	8.02e-05	0.000771	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	8.01e-05	0.00077	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—IL6—osteoporosis	7.77e-05	0.000746	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—IL6R—osteoporosis	7.75e-05	0.000745	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—FDPS—osteoporosis	7.65e-05	0.000735	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PKM—osteoporosis	7.65e-05	0.000735	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—RAP1A—osteoporosis	7.57e-05	0.000727	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IRS1—osteoporosis	7.49e-05	0.00072	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—IL6—osteoporosis	7.49e-05	0.00072	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—IL6—osteoporosis	7.43e-05	0.000714	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—TGFB1—osteoporosis	7.41e-05	0.000712	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TGFB1—osteoporosis	7.35e-05	0.000707	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PGLS—osteoporosis	7.25e-05	0.000697	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GPD2—osteoporosis	7.25e-05	0.000697	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—POMC—osteoporosis	7.22e-05	0.000693	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.21e-05	0.000693	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—IL6—osteoporosis	7.14e-05	0.000686	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—IL6—osteoporosis	7.14e-05	0.000686	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.08e-05	0.00068	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	7.06e-05	0.000679	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL6R—osteoporosis	7.04e-05	0.000676	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TGFB1—osteoporosis	7.03e-05	0.000676	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IGF1—osteoporosis	6.94e-05	0.000667	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—IL6—osteoporosis	6.88e-05	0.000661	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—IL6—osteoporosis	6.88e-05	0.000661	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TNF—osteoporosis	6.87e-05	0.00066	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—FGA—osteoporosis	6.86e-05	0.00066	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—IL6—osteoporosis	6.85e-05	0.000658	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TGFB1—osteoporosis	6.76e-05	0.000649	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TGFB1—osteoporosis	6.76e-05	0.000649	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ATIC—osteoporosis	6.63e-05	0.000637	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PNP—osteoporosis	6.63e-05	0.000637	CbGpPWpGaD
Rufinamide—ALB—Metabolism—FDPS—osteoporosis	6.57e-05	0.000632	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PKM—osteoporosis	6.57e-05	0.000632	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TNF—osteoporosis	6.57e-05	0.000631	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TGFB1—osteoporosis	6.52e-05	0.000626	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TGFB1—osteoporosis	6.52e-05	0.000626	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—IL6—osteoporosis	6.52e-05	0.000626	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—TNF—osteoporosis	6.41e-05	0.000616	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TNF—osteoporosis	6.31e-05	0.000606	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TNF—osteoporosis	6.31e-05	0.000606	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	6.26e-05	0.000601	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—FGB—osteoporosis	6.24e-05	0.0006	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PGLS—osteoporosis	6.23e-05	0.000599	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GPD2—osteoporosis	6.23e-05	0.000599	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	6.17e-05	0.000593	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TNF—osteoporosis	6.08e-05	0.000585	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TNF—osteoporosis	6.08e-05	0.000585	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PNP—osteoporosis	5.7e-05	0.000548	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ATIC—osteoporosis	5.7e-05	0.000548	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CA2—osteoporosis	5.64e-05	0.000542	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—OXCT1—osteoporosis	5.64e-05	0.000542	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—IL6—osteoporosis	5.54e-05	0.000532	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MGLL—osteoporosis	5.49e-05	0.000528	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	5.48e-05	0.000527	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—IL6—osteoporosis	5.31e-05	0.00051	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—IL6—osteoporosis	5.3e-05	0.000509	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—IL6—osteoporosis	5.18e-05	0.000497	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—IL6—osteoporosis	5.09e-05	0.000489	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—IL6—osteoporosis	5.09e-05	0.000489	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—IL6—osteoporosis	4.91e-05	0.000472	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—IL6—osteoporosis	4.91e-05	0.000472	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CA2—osteoporosis	4.85e-05	0.000466	CbGpPWpGaD
Rufinamide—ALB—Metabolism—OXCT1—osteoporosis	4.85e-05	0.000466	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—IL6—osteoporosis	4.84e-05	0.000465	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MGLL—osteoporosis	4.72e-05	0.000454	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—IDH2—osteoporosis	4.67e-05	0.000449	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TGFB1—osteoporosis	4.58e-05	0.00044	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.45e-05	0.000428	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP27A1—osteoporosis	4.39e-05	0.000422	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TNF—osteoporosis	4.28e-05	0.000411	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ACP5—osteoporosis	4.27e-05	0.000411	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MYC—osteoporosis	4.17e-05	0.000401	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TGFB1—osteoporosis	4.16e-05	0.0004	CbGpPWpGaD
Rufinamide—ALB—Metabolism—IDH2—osteoporosis	4.01e-05	0.000386	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TPI1—osteoporosis	3.97e-05	0.000382	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP27A1—osteoporosis	3.77e-05	0.000363	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—POMC—osteoporosis	3.76e-05	0.000361	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—P4HB—osteoporosis	3.73e-05	0.000359	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ACP5—osteoporosis	3.67e-05	0.000353	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GAPDH—osteoporosis	3.67e-05	0.000352	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.63e-05	0.000348	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—RAP1A—osteoporosis	3.57e-05	0.000343	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—FDPS—osteoporosis	3.55e-05	0.000341	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PKM—osteoporosis	3.55e-05	0.000341	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.46e-05	0.000332	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—IL6—osteoporosis	3.45e-05	0.000332	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TPI1—osteoporosis	3.41e-05	0.000328	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PGLS—osteoporosis	3.36e-05	0.000323	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GPD2—osteoporosis	3.36e-05	0.000323	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	3.29e-05	0.000316	CbGpPWpGaD
Rufinamide—ALB—Metabolism—P4HB—osteoporosis	3.21e-05	0.000308	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GAPDH—osteoporosis	3.15e-05	0.000303	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL6—osteoporosis	3.14e-05	0.000301	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ATIC—osteoporosis	3.08e-05	0.000296	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PNP—osteoporosis	3.08e-05	0.000296	CbGpPWpGaD
Rufinamide—ALB—Metabolism—RAP1A—osteoporosis	3.07e-05	0.000295	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ENO1—osteoporosis	2.89e-05	0.000277	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PSMA5—osteoporosis	2.84e-05	0.000273	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PSMA2—osteoporosis	2.84e-05	0.000273	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IGF1—osteoporosis	2.83e-05	0.000272	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.68e-05	0.000257	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CA2—osteoporosis	2.62e-05	0.000251	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—OXCT1—osteoporosis	2.62e-05	0.000251	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MGLL—osteoporosis	2.55e-05	0.000245	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ENO1—osteoporosis	2.48e-05	0.000238	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PSMA2—osteoporosis	2.44e-05	0.000235	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PSMA5—osteoporosis	2.44e-05	0.000235	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP19A1—osteoporosis	2.31e-05	0.000222	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—IDH2—osteoporosis	2.17e-05	0.000208	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.04e-05	0.000196	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP19A1—osteoporosis	1.98e-05	0.000191	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ACP5—osteoporosis	1.98e-05	0.00019	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ADCY5—osteoporosis	1.89e-05	0.000181	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GPX1—osteoporosis	1.88e-05	0.000181	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TPI1—osteoporosis	1.84e-05	0.000177	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MTHFR—osteoporosis	1.73e-05	0.000167	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—P4HB—osteoporosis	1.73e-05	0.000166	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GAPDH—osteoporosis	1.7e-05	0.000163	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TGFB1—osteoporosis	1.69e-05	0.000163	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—RAP1A—osteoporosis	1.66e-05	0.000159	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ADCY5—osteoporosis	1.62e-05	0.000156	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GPX1—osteoporosis	1.61e-05	0.000155	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTHFR—osteoporosis	1.49e-05	0.000143	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—POMC—osteoporosis	1.39e-05	0.000133	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ENO1—osteoporosis	1.34e-05	0.000129	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PSMA5—osteoporosis	1.32e-05	0.000127	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PSMA2—osteoporosis	1.32e-05	0.000127	CbGpPWpGaD
Rufinamide—ALB—Metabolism—POMC—osteoporosis	1.19e-05	0.000115	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.07e-05	0.000103	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ADCY5—osteoporosis	8.75e-06	8.4e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GPX1—osteoporosis	8.72e-06	8.38e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTHFR—osteoporosis	8.04e-06	7.73e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—POMC—osteoporosis	6.43e-06	6.18e-05	CbGpPWpGaD
